Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-25
2008-03-25
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S601000, C514S613000, C548S495000, C564S080000, C564S123000
Reexamination Certificate
active
07348353
ABSTRACT:
The invention provides compounds of formula (I) wherein m, n, A, R, R′, R″, R0, X and Y are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals in the treatment of e.g. nervous system disorders
REFERENCES:
patent: 4129658 (1978-12-01), Berthold
patent: 5516904 (1996-05-01), Chandraratna
patent: 6313071 (2001-11-01), Ikegaya et al.
patent: 0849256 (1996-08-01), None
patent: WO 97 08133 (1995-08-01), None
patent: WO 96 10012 (1995-09-01), None
patent: WO 97 48697 (1997-06-01), None
patent: WO 99 02497 (1999-01-01), None
patent: WO 99 62869 (1999-06-01), None
patent: WO 0234711 (2002-05-01), None
patent: WO 02 46166 (2002-06-01), None
patent: WO 02 062323 (2002-08-01), None
Auberson Yves
Gasparini Fabrizio
Ofner Silvio
Davis Zinna N.
McAvoy Cozette M.
Novartis AG
Waibel Peter J.
LandOfFree
Acetylene derivatives having mGluR 5 antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylene derivatives having mGluR 5 antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylene derivatives having mGluR 5 antagonistic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2814093